BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23161469)

  • 1. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
    Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
    Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
    Moorman JP; Wang JM; Zhang Y; Ji XJ; Ma CJ; Wu XY; Jia ZS; Wang KS; Yao ZQ
    J Immunol; 2012 Jul; 189(2):755-66. PubMed ID: 22706088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
    Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
    Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
    Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.
    Kared H; Fabre T; Bédard N; Bruneau J; Shoukry NH
    PLoS Pathog; 2013; 9(6):e1003422. PubMed ID: 23818845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.
    Oomizu S; Arikawa T; Niki T; Kadowaki T; Ueno M; Nishi N; Yamauchi A; Hirashima M
    Clin Immunol; 2012 Apr; 143(1):51-8. PubMed ID: 22341088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.
    Mayer E; Bannert C; Gruber S; Klunker S; Spittler A; Akdis CA; Szépfalusi Z; Eiwegger T
    PLoS One; 2012; 7(1):e29355. PubMed ID: 22272233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
    Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
    Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble galectin 9 potently enhanced regulatory T-cell formation, a pathway impaired in patients with intracranial aneurysm.
    Zhao MG; Liang GB; Zhang HF; Zhao GF; Luo YH
    Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1206-1212. PubMed ID: 29978574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
    Hamza E; Gerber V; Steinbach F; Marti E
    Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection.
    Li S; Jones KL; Woollard DJ; Dromey J; Paukovics G; Plebanski M; Gowans EJ
    Immunol Cell Biol; 2007; 85(3):197-204. PubMed ID: 17199111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection.
    Ebinuma H; Nakamoto N; Li Y; Price DA; Gostick E; Levine BL; Tobias J; Kwok WW; Chang KM
    J Virol; 2008 May; 82(10):5043-53. PubMed ID: 18337568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
    Zhang Y; Ma CJ; Wang JM; Ji XJ; Wu XY; Jia ZS; Moorman JP; Yao ZQ
    PLoS One; 2011; 6(5):e19664. PubMed ID: 21637332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
    Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R
    Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.